NCT00135564View on ClinicalTrials.gov

Study to Evaluate GlaxoSmithKline (GSK) Biologicals' MenC-TT and Hib-MenC-TT or Meningitec™ in Healthy Toddlers

PHASE2CompletedINTERVENTIONAL

Enrollment

500

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

July 31, 2003

Study Completion Date

July 31, 2003

Conditions

Infections, Meningococcal

Interventions

BIOLOGICAL

MenC-TT

BIOLOGICAL

Hib-MenC-TT

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY